ClinicalTrials.Veeva

Menu

Tamsulosin Assisted Ureteral Access Sheath Insertion

S

Sengkang General Hospital

Status and phase

Unknown
Phase 3

Conditions

Renal Stone
Urolithiasis
Retrograde Intrarenal Surgery

Treatments

Drug: Tamsulosin

Study type

Interventional

Funder types

Other

Identifiers

NCT05197088
2019/2156

Details and patient eligibility

About

Aim is to study if 1 week of pre operative tamsulosin would enable easier insertion of ureteral access sheath in primary retrograde intrarenal surgery for renal stone disease

Enrollment

110 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • renal stone undergoing retrograde intrarenal surgery

Exclusion criteria

  • not on tamsulosin or other alpha blockers regularly
  • ureteral stricture
  • concurrent ureteric stone

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Double Blind

110 participants in 2 patient groups

1 week of tamsulosin
Experimental group
Description:
1 week of tamsulosin tablet 400mcg once a night
Treatment:
Drug: Tamsulosin
no additional medication
No Intervention group

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems